Prasant Jena

Dr. Prasant Jena

Department of Pediatrics, Cedars Sinai Medical Center
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LSLili Sheng
Lili Sheng
Prasant JenaPrasant Jena
Prasant Jena
HLHui-Xin Liu
Hui-Xin Liu
KKKaren M. Kalanetra
Karen M. Kalanetra
FGFrank Gonzalez
Frank Gonzalez
Yu-Jui Yvonne WanYu-Jui Yvonne Wan
Yu-Jui Yvonne Wan
This study aims to uncover how specific bacteria and bile acids (BAs) contribute to steatosis induced by diet and farnesoid X receptor (FXR) deficiency in both genders. A control diet (CD) and Western diet (WD), which contains high fat and carbohydrate, were used to feed wild type (WT) and FXR knockout (KO) mice followed by phenotyping characterization as well as BA and microbiota profiling. Our data revealed that male WD-fed FXR KO mice had the most severe steatosis and highest hepatic and serum lipids as well as insulin resistance among the eight studied groups. Gender differences in WD-induced steatosis, insulin sensitivity, and predicted microbiota functions were all FXR-dependent. FXR deficiency enrichedDesulfovibrionaceae,Deferribacteraceae, andHelicobacteraceae, which were accompanied by increased hepatic taurine-conjugated cholic acid and β-muricholic acid as well as hepatic and serum lipids. Additionally, distinct microbiota profiles were found in WD-fed WT mice harboring simple steatosis and CD-fed FXR KO mice, in which the steatosis had a potential to develop into liver cancer. Together, the presented data revealed FXR-dependent concomitant relationships between gut microbiota, BAs, and metabolic diseases in both genders. Gender differences in BAs and microbiota may account for gender dissimilarity in metabolism and metabolic diseases.


11 September 2017 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
LSLili Sheng
Lili Sheng
Prasant JenaPrasant Jena
Prasant Jena
YHYing Hu
Ying Hu
HLHui-Xin Liu
Hui-Xin Liu
NNNidhi Nagar
Nidhi Nagar
Yu-Jui Yvonne WanYu-Jui Yvonne Wan
Yu-Jui Yvonne Wan

1 August 2017 in The American Journal of Pathology
Verified
Journal Article
Closed access
Prasant JenaPrasant Jena
Prasant Jena
LSLili Sheng
Lili Sheng
HLHui-Xin Liu
Hui-Xin Liu
KKKaren M. Kalanetra
Karen M. Kalanetra
AMAnnie Mirsoian
Annie Mirsoian
Yu-Jui Yvonne WanYu-Jui Yvonne Wan
Yu-Jui Yvonne Wan

1 May 2012 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
BKBhavesh D. Kevadiya
Bhavesh D. Kevadiya
Tapan A. Patel, Ph.D.Tapan A. Patel, Ph.D.
Tapan A. Patel, Ph.D.
DJDevendrasinh D. Jhala
Devendrasinh D. Jhala
RTRahul P. Thumbar
Rahul P. Thumbar
HBHarshad Brahmbhatt
Harshad Brahmbhatt
HBHari C. Bajaj
Hari C. Bajaj

10 February 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
ZSZhenrui Shi
Zhenrui Shi
XWXuesong Wu
Xuesong Wu
Sebastian YuSebastian Yu
Sebastian Yu
MHMindy Huynh
Mindy Huynh
Prasant JenaPrasant Jena
Prasant Jena
SHSamuel T. Hwang
Samuel T. Hwang